Similar articles

• [Significance of neoadjuvant chemotherapy for gastric cancer].

  Fujii M, Kochi M, Mochizuki F. Fujii M, et al. Gan To Kagaku Ryoho. 2000 Nov;27(13):2028-32. Gan To Kagaku Ryoho. 2000. PMID: 11103233 Review. Japanese.
• [Evaluation of neoadjuvant chemotherapy with paclitaxel, 5-fluorouracil and cisplatin for advanced gastric cancer with pyloric stenosis].

  Yamaguchi K, Nakagawa S, Yabusaki H, Nashimoto A. Yamaguchi K, et al. Gan To Kagaku Ryoho. 2007 Dec;34(13):2241-4. Gan To Kagaku Ryoho. 2007. PMID: 18079622 Japanese.
• [Neoadjuvant chemotherapy in advanced stomach cancer--a case of complete response].

  Káposztás Z, Cseke L, Kalmár K, Horváth OP. Káposztás Z, et al. Magy Seb. 2002 Oct;55(5):321-4. Magy Seb. 2002. PMID: 12474518 Review. Hungarian.
• [Neoadjuvant chemotherapy for locally advanced gastric cancer].

  Kalmár K, Cseke L, Káposztás Z, Horváth G, Varga E. Kalmár K, et al. Magy Seb. 2003 Oct;56(5):177-84. Magy Seb. 2003. PMID: 15022621 Hungarian.
• Neoadjuvant chemotherapy for locally advanced carcinoma of the lower oesophagus and oesophago-gastric junction.

  Forshaw MJ, Gossage JA, Chrystal K, Cheong K, Atkinson S, Botha A, Harper PG, Mason RC. Forshaw MJ, et al. Eur J Surg Oncol. 2006 Dec;32(10):1114-8. doi: 10.1016/j.ejso.2006.02.025. Epub 2006 Apr 18. Eur J Surg Oncol. 2006. PMID: 16621430